324 related articles for article (PubMed ID: 33931075)
1. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.
Sun X; He Z; Guo L; Wang C; Lin C; Ye L; Wang X; Li Y; Yang M; Liu S; Hua X; Wen W; Lin C; Long Z; Zhang W; Li H; Jian Y; Zhu Z; Wu X; Lin H
J Exp Clin Cancer Res; 2021 Apr; 40(1):149. PubMed ID: 33931075
[TBL] [Abstract][Full Text] [Related]
2. ALG3 Is Activated by Heat Shock Factor 2 and Promotes Breast Cancer Growth.
Yang Y; Zhou Y; Xiong X; Huang M; Ying X; Wang M
Med Sci Monit; 2018 May; 24():3479-3487. PubMed ID: 29799832
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185.
Liu L; Zhu Y; Liu AM; Feng Y; Chen Y
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7457-7468. PubMed ID: 31539133
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy.
Liu P; Lin C; Liu Z; Zhu C; Lin Z; Xu D; Chen J; Huang Q; Li CY; Hou L; Pan JA; Liu X
Cell Mol Life Sci; 2022 Jun; 79(7):352. PubMed ID: 35676564
[TBL] [Abstract][Full Text] [Related]
5. GDF15 Contributes to Radioresistance by Mediating the EMT and Stemness of Breast Cancer Cells.
Zhao X; Liu X; Hu S; Pan Y; Zhang J; Tai G; Shao C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142823
[TBL] [Abstract][Full Text] [Related]
6. Correction to: ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.
Sun X; He Z; Guo L; Wang C; Lin C; Ye L; Wang X; Li Y; Yang M; Liu S; Hua X; Wen W; Lin C; Long Z; Zhang W; Li H; Jian Y; Zhu Z; Wu X; Lin H
J Exp Clin Cancer Res; 2022 Mar; 41(1):117. PubMed ID: 35361247
[No Abstract] [Full Text] [Related]
7. ALG3 Promotes Peritoneal Metastasis of Ovarian Cancer through Increasing Interaction of α1,3-mannosylated uPAR and ADAM8.
Cui X; Pei X; Wang H; Feng P; Qin H; Liu S; Yan Q; Liu J
Cells; 2022 Oct; 11(19):. PubMed ID: 36231102
[TBL] [Abstract][Full Text] [Related]
8. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
[TBL] [Abstract][Full Text] [Related]
9. Silencing human epidermal growth factor receptor-3 radiosensitizes human luminal A breast cancer cells.
He G; Di X; Yan J; Zhu C; Sun X; Zhang S
Cancer Sci; 2018 Dec; 109(12):3774-3782. PubMed ID: 30259607
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5p.
Zhang S; Wang B; Xiao H; Dong J; Li Y; Zhu C; Jin Y; Li H; Cui M; Fan S
Thorac Cancer; 2020 Jul; 11(7):1801-1816. PubMed ID: 32374522
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.
Turner BC; Haffty BG; Narayanan L; Yuan J; Havre PA; Gumbs AA; Kaplan L; Burgaud JL; Carter D; Baserga R; Glazer PM
Cancer Res; 1997 Aug; 57(15):3079-83. PubMed ID: 9242428
[TBL] [Abstract][Full Text] [Related]
12. Arabidopsis thaliana ALG3 mutant synthesizes immature oligosaccharides in the ER and accumulates unique N-glycans.
Kajiura H; Seki T; Fujiyama K
Glycobiology; 2010 Jun; 20(6):736-51. PubMed ID: 20356820
[TBL] [Abstract][Full Text] [Related]
13. Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R.
Chen K; Li L; Qu S; Pan X; Sun Y; Wan F; Yu B; Zhou L; Zhu X
Aging (Albany NY); 2020 Nov; 12(24):25599-25613. PubMed ID: 33234740
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor ATF3 mediates the radioresistance of breast cancer.
Zhao W; Sun M; Li S; Chen Z; Geng D
J Cell Mol Med; 2018 Oct; 22(10):4664-4675. PubMed ID: 30117642
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
[TBL] [Abstract][Full Text] [Related]
16. ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL.
Li JY; Li YY; Jin W; Yang Q; Shao ZM; Tian XS
J Exp Clin Cancer Res; 2012 Dec; 31(1):102. PubMed ID: 23259599
[TBL] [Abstract][Full Text] [Related]
17. A radiosensitizer, gallotannin-rich extract from Bouea macrophylla seeds, inhibits radiation-induced epithelial-mesenchymal transition in breast cancer cells.
Kantapan J; Paksee S; Duangya A; Sangthong P; Roytrakul S; Krobthong S; Suttana W; Dechsupa N
BMC Complement Med Ther; 2021 Jul; 21(1):189. PubMed ID: 34217266
[TBL] [Abstract][Full Text] [Related]
18. CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.
Li H; Che J; Jiang M; Cui M; Feng G; Dong J; Zhang S; Lu L; Liu W; Fan S
Cell Commun Signal; 2020 Sep; 18(1):152. PubMed ID: 32943060
[TBL] [Abstract][Full Text] [Related]
19. Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia.
Liu B; Ma X; Liu Q; Xiao Y; Pan S; Jia L
Cell Death Dis; 2018 Jun; 9(6):688. PubMed ID: 29880818
[TBL] [Abstract][Full Text] [Related]
20. miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα.
Luo M; Ding L; Li Q; Yao H
Breast Cancer; 2017 Sep; 24(5):673-682. PubMed ID: 28138801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
